Oxidized products of cholesterol: Dietary and metabolic origin, and proatherosclerotic effects (review)

Journal of Nutritional Biochemistry

Volumn 13, Issue 12, 2002, Pages 700-710

  Leonarduzzi, Gabriella ^a   Sottero, Barbara ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; Atherosclerosis; Inflammatory cytokines; Oxysterols; Vascular cells

Indexed keywords

CHEMOKINE; CHOLESTEROL OXIDASE; CYTOKINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABSORPTION; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BIOACCUMULATION; BIOCHEMISTRY; DIET; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; INFLAMMATION; LIPID OXIDATION; METABOLISM; NONHUMAN; OXIDATION; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; UPREGULATION; VASCULARIZATION;

EID: 0036903407     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00222-X     Document Type: Review

References (135)

1. McNamara D.J. Dietary cholesterol and atherosclerosis. Biochim Biophys Acta. 1529:2000;310-320.
2. Renaud S., Lanzmann-Petithory D. Coronary heart disease dietary links and pathogenesis . Public Health Nutr. 4:2001;459-474.
3. Kritchevsky D. Diet and atherosclerosis. J Nutr Health Aging. 5:2001;155-159.
4. Kromhout D. Diet and cardiovascular diseases. J Nutr Health Aging. 5:2001;144-149.
5. Anitschkow N., Chalatow S. Über Experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger Pathologischer Prozesse. Zentralbl Allg Pathol Anat. 24:1913;1-9.
6. Chobanian A.V., Menzoian J.O., Shipman J., Heath K., Haudenschild C. Effects of endothelial denudation and cholesterol feeding on in vivo transport of albumin, glucose, and water across rabbit carotid artery. Circ Res. 53:1983;805-814.
7. 3H-inulin endothelial permeability in cholesterol induced rabbit atherogenesis. Res Commun Chem Pathol Pharmacol. 47:1985;85-96.
8. Menzoian J.O., Haudenschild C., Shipman J., Chobanian A.V. Functional alteration of endothelium by short-term cholesterol feeding. Exp Mol Pathol. 45:1986;270-278.
9. Coutard M., Osborne-Pellegrin M.J. "Spontaneous" endothelial injury and lipid accumulation in the rat caudal artery. Am J Pathol. 122:1986;120-128.
10. Rifkind B.M. Diet, plasma cholesterol and coronary heart disease. J Nutr. 116:1986;1578-1580.
11. Ross R. The pathogenesis of atherosclerosis-An update. N Engl J Med. 314:1986;488-500.
12. Toda T., Leszczynski D., Kummerow F. Angiotoxic effects of dietary 7-ketocholesterol in chick aorta. Paroi Arterielle. 7:1981;167-176.
13. Imai H., Nakamura H. Short-term responses to cholesterol and oxygenated derivatives. Fed Proc. 39:1980;772a.
14. Peng S.K., Hu B., Morin R.J. Angiotoxicity and atherogenicity of cholesterol oxides. J Clin Lab Anal. 5:1991;144-152.
15. Boissonneault G.A., Hennig B., Ouyang C.-M. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. Proc Soc Exp Biol Med. 196:1991;338-343.
16. Leonarduzzi G., Sevanian A., Sottero B., Arkan M.C., Biasi F., Chiarpotto E., Basaga H., Poli G. Up-regulation of the fibrogenic cytokine TGF-β1 by oxysterols a mechanistic link between cholesterol and atherosclerosis . FASEB J. 15:2001;1619-1621.
17. Imai H., Werthessen N.T., Subramanyam V., LeQuesne P.W., Soloway A.H., Kanisawa M. Angiotoxicity of oxygenated sterols and possible precursors. Science. 207:1980;651-653.
18. Peng S.-K., Taylor C.B., Hill J.C., Morin R.J. Cholesterol oxidation derivatives and arterial endothelial damage. Atherosclerosis. 54:1985;121-133.
19. Smith L.L. Smith L.L. Cholesterol autoxidation. 1981;Plenum Press, New York.
20. Smith L.L., Johnson B.H. Biological activities of oxysterols. Free Radic Biol Med. 7:1989;285-332.
21. Luu B., Moog C. Oxysterols biological activities and physicochemical studies . Biochimie. 73:1991;1317-1320.
22. Smith L.L. Review of progress in sterol oxidation 1987-1995 . Lipids. 31:1996;453-487.
23. Guardiola F., Codony R., Addis P.B., Rafecas M., Boatella J. Biological effects of oxysterols current status . Food Chem Toxicol. 34:1996;193-211.
24. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 142:1999;1-28.
25. Russell D.W. Oxysterol biosynthetic enzymes. Biochim Biophys Acta. 1529:2000;126-135.
26. Schroepfer G.J. Jr. Oxysterols modulators of cholesterol metabolism and other processes . Physiol Rev. 80:2000;361-554.
27. Björkhem I., Diczfalusy U., Lütjohann D. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr Opin Lipidol. 10:1999;161-165.
28. Lyons M.A., Brown A.J. Molecules in focus 7-ketocholesterol . Int J Biochem Cell Biol. 31:1999;369-375.
29. Accad M., Farese R.V. Jr. Cholesterol homeostasis a role for oxysterols . Curr Biol. 8:1998;R601-R604.
30. Lund E.G., Kerr T.A., Sakai J., Li W.-P., Russell D.W. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem. 273:1998;34316-34327.
31. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA. 96:1999;11041-11048.
32. Wolf G. The role of oxysterols in cholesterol homeostasis. Nutr Rev. 57:1999;196-198.
33. Nes W.D., Lukyanenko Y.O., Jia Z.H., Quideau S., Howald W.N., Pratum T.K., West R.R., Hutson J.C. Identification of the lipophilic factor produced by macrophages that stimulates steroidogenesis. Endocrinology. 141:2000;953-958.
34. Brown M.S., Goldstein J.L. The SREBP pathway regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor . Cell. 89:1997;331-340.
35. Schwarz M., Lund E.G., Setchell K.D.R., Kayden H.J., Zerwekh J.E., Björkhem I., Herz J., Russell D.W. Disruption of cholesterol 7α-hydroxylase. J Biol Chem. 271:1996;18024-18031.
36. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., Björkhem I. Cholesterol homeostasis in human brain evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation . Proc Natl Acad Sci USA. 93:1996;9799-9804.
37. Babiker A., Andersson O., Lindblom D., van der Linden J., Wiklund B., Lutjohann D., Diczfalusy U., Björkhem I. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase evidence that most of this steroid in the circulation is of pulmonary origin . J Lipid Res. 40:1999;1417-1425.
38. Bruce C., Chouinard R.A. Jr, Tall A.R. Plasma lipid transfer proteins, high-density lipoproteins and reverse cholesterol transport. Annu Rev Nutr. 18:1998;297-330.
39. Hodis H.N., Crawford D.W., Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel further evidence for the role of cholesterol oxidation in atherosclerosis . Atherosclerosis. 89:1991;117-126.
40. Addis P.B., Emanuel H.A., Bergmann S.D., Zavoral J.H. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radic Biol Med. 7:1989;179-182.
41. Chang Y.H., Abdalla D.S., Sevanian A. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein. Free Radic Biol Med. 23:1997;202-214.
42. Carpenter K.L., Taylor S.E., van der Veen C., Williamson B.K., Ballantine J.A., Mitchinson M.J. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta. 1256:1995;141-150.
43. Carpenter K.L., Taylor S.E., Ballantine J.A., Fussell B., Halliwell B., Mitchinson M.J. Lipids and oxidized lipids in human atheroma and normal aorta. Biochim Biophys Acta. 1167:1993;121-130.
44. Kumar N., Singhal O.P. Cholesterol oxides and atherosclerosis a review . J Sci Food Agric. 55:1991;497-510.
45. Björkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.-J., Duan C., Lund E. Atherosclerosis and sterol 27-hydroxylase evidence for a role of this enzyme in elimination of cholesterol from human macrophages . Proc Natl Acad Sci USA. 91:1994;8592-8596.
46. Guardiola F., Codony R., Miskin D., Rafecas M., Boatella J. Oxysterol formation in egg powder and relationship with other quality parameters. J Agric Food Chem. 43:1995;1903-1907.
47. Guardiola F., Codony R., Rafecas M., Grau A., Jordan A., Boatella J. Oxysterol formation in spray-dried egg processed and stored under various conditions prevention and relationship with other quality parameters . J Agric Food Chem. 45:1997;2229-2243.
48. Lai S.-M., Gray J.I., Buckley D.J., Kelley P.M. Influence of free radicals and other factors on formation of cholesterol oxidation products in spray-dried whole egg. J Agric Food Chem. 43:1995;1127-1131.
49. Nielsen J.H., Olsen C.E., Duedahl C., Skibsted L.H. Isolation and quantification of cholesterol oxides in dairy products by selected ion monitoring mass spectrometry. J Dairy Res. 62:1995;101-113.
50. Angulo A.J., Romera J.M., Ramirez M., Gil A. Determination of cholesterol oxides in diary products. Effect of storage conditions. J Agric Food Chem. 45:1997;4318-4323.
51. Finocchiaro E.T., Lee K., Richard T. Identification and quantification of cholesterol oxides in grated cheese and bleached butter oil. J Am Oil Chem Soc. 61:1984;877-883.
52. Higley N.A., Taylor S.L., Herian A.M., Lee K. Cholesterol oxides in processed meats. Meat Sci. 16:1986;175-188.
53. Osada K., Kodama T., Cui L., Yamada K., Sugano M. Levels and formation of oxidized cholesterol in processed marine foods. J Agric Food Chem. 41:1993;1893-1898.
54. Ohshima T., Li N., Koizumi C. Oxidative decomposition of cholesterol in fish products. J Am Oil Chem Soc. 70:1993;595-600.
55. Addis P.B. Occurrence of lipid oxidation products in foods. Food Chem Toxic. 24:1986;1021-1030.
56. Finocchiaro E.T., Richardson T. Sterol oxides in food stuffs a review . J Food Prot. 46:1983;917-925.
57. Cheng D., Chang C.C., Qu X., Chang T.Y. Activation of acyl-coenzymeA cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system . J Biol Chem. 270:1995;685-695.
58. Smith L.L. Cholesterol autoxidation 1981-1986. Chem Phys Lipids. 44:1987;87-125.
59. Sander B.D., Addis P.B., Park S.W., Smith D.E. Quantification of cholesterol oxidation products in a variety of foods. J Food Protect. 52:1989;109-114.
60. Emanuel H.A., Hassel C.A., Addis P.B., Bergmann S.D., Zavoral J.H. Plasma cholesterol oxidation products in human subjects fed a meal rich in oxysterols. J Food Sci. 56:1991;843-847.
61. Linseisen J., Wolfram G. Absorption of cholesterol oxidation products from ordinary foodstuff in humans. Ann Nutr Metab. 42:1998;221-230.
62. Bascoul J., Domerque N., Mourot J., Dery G., Crastes de Paulet A. Intestinal absorption and fecal excretion of 5,6α-epoxy-5α-cholestan-3β-ol by the male Wistar rat. Lipids. 21:1986;744-747.
63. Osada K., Sasaki E., Sugano M. Lymphatic absorption of oxidized cholesterol. Lipids. 29:1994;555-559.
64. Vine D.F., Croft K.D., Beilin L.J., Mamo J.C. Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids. 32:1997;887-893.
65. Krut L.H., Yang J.W., Schroepfer G.J. Jr, Ostlund R.E. Jr. The effect of oxidizing cholesterol on gastrointestinal absorption, plasma clearance, tissue distribution, and processing by endothelial cells. Arterioscler Thromb Vasc Biol. 17:1997;778-785.
66. Redgrave T.G. Formation and metabolism of chylomicrons. Int Rev Physiol. 28:1983;103-130.
67. Groot P.H.E., van Berkel T.J.C., van Tol A. Relative contributions of parenchymal and non-parenchymal (sinusoidal) liver cells in the uptake of chylomicron remnants. Metabolism. 30:1981;792-797.
68. van Dijk M.C.M., Pieters M., van Berkel T.J.C. Kinetics of biliary secretion of chylomicron remnant cholesterol (esters) in the rat. Eur J Biochem. 211:1993;781-787.
69. Hodis H.N., Chauhan A., Hashimoto S., Crawford D.W., Sevanian A. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol-fed rabbits independently of its plasma cholesterol-lowering effect. Atherosclerosis. 96:1992;125-134.
70. Freyschuss A., Stiko-Rahm A., Swedenborg J., Henriksson P., Björkhem I., Berglund L., Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta of hypercholesterolemic rabbits. J Clin Invest. 91:1993;1282-1288.
71. Stalenhoef A.F., Kleinveld H.A., Kosmeijer-Schuil T.G., Demacker P.N., Katan M.B. In vivo oxidised cholesterol in atherosclerosis. Atherosclerosis. 98:1993;113-114.
72. Mol M.J., De Rijke Y., Demacker P.N., Stalenhoef A.F. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking effects of vitamin E treatment . Atherosclerosis. 129:1997;169-176.
73. Javitt N.B. Hep G2 cells as a resource for metabolic studies lipoprotein, cholesterol, and bile acids . FASEB J. 4:1990;161-168.
74. Russell D.W., Setchell K.D. Bile acid biosynthesis. Biochemistry. 31:1992;4737-4749.
75. Björkhem I. Mechanism of degradation of the steroids side chain in the formation of bile acids. J Lipid Res. 33:1992;455-472.
76. Reiss A.B., Martin K.O., Javitt N.B., Martin D.W., Grossi E.A., Galloway A.C. Sterol 27-hydroxylase high levels of activity in vascular endothelium . J Lipid Res. 35:1994;1026-1030.
77. Skrede S., Björkhem I., Kvittingen E.A., Buchmann M.S., Lie O., East C., Grundy S. Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and deficiency of this activity in cerebrotendinous xanthomatosis. J Clin Invest. 78:1986;729-735.
78. Pedersen J., Oftebro H., Björkhem I. Reconstitution of C27-steroid 26-hydroxylase activity from bovine brain mitochondrial. Biochem Int. 18:1989;615-622.
79. Schwarz M., Lund E.G., Lathe R., Björkhem I., Russell D.W. Identification and characterization of a mouse oxysterol 7α-hydrolase cDNA. J Biol Chem. 272:1997;23995-24001.
80. Björkhem I., Einarsson K., Johansson G. Formation and metabolism of 3β-hydroxycholest-5-en-7-one and cholest-5-ene-3β,7β-diol. Acta Chem Scand. 22:1968;1595-1605.
81. Shoda J., Toll A., Axelson M.P., Pieper F., Wikvall K., Sjorvall J. Formation of 7α- and 7β-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria. Hepatology. 17:1993;395-403.
82. Erickson S.K., Cooper A.D., Matsui S.M., Gould R.G. 7-Ketocholesterol, Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro. J Biol Chem. 252:1977;5186-5193.
83. Breuer O., Sudjana-Sugiaman E., Eggertsen G., Chiang J.Y., Björkhem I. Cholesterol 7α-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur J Biochem. 215:1993;705-710.
84. Lyons M.A., Brown A.J. Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. Lipids. 36:2001;701-711.
85. Lyons M.A., Brown A.J. 7-Ketocholesterol delivered to mice in chylomicron remnant-like particles is rapidly metabolised, excreted and does not accumulate in aorta. Biochim Biophys Acta. 1530:2001;209-218.
86. Kritharides L., Jessup W., Mander E.L., Dean R.T. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol. 15:1995;276-289.
87. Gelissen I.C., Brown A.J., Mander E.L., Kritharides L., Dean R.T., Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem. 271:1996;17852-17860.
88. Maor I., Kaplan M., Hayek T., Vaya J., Hoffman A., Aviram M. Oxidized monocyte derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem Biophys Res Commun. 269:2000;775-780.
89. Maor I., Aviram M. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester. J Lipid Res. 35:1994;803-819.
90. Maor I., Mandel H., Aviram M. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-ketocholesterol. Arterioscler Thromb Vasc Biol. 15:1995;1378-1387.
91. Brown A.J., Mander E.L., Gelissen I.C., Kritharides L., Dean R.T., Jessup W. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells accumulation of oxidized esters in lysosomes . J Lipid Res. 41:2000;226-236.
92. Jepson C.A., Harrison J.A., Kraemer F.B., Yeman S.T. Down-regulation of hormone-sensitive lipase in sterol ester-laden J774.2 macrophages. Biochem J. 318:1996;173-177.
93. Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med. 28:2000;208-218.
94. Gelissen I.C., Rye K.A., Brown A.J., Dean R.T., Jessup W. Oxysterols efflux from macrophage foam cells the essential role of acceptor phospholipid . J Lipid Res. 40:1999;1636-1646.
95. Björkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.J., Duann C., Lund E. Atherosclerosis and sterol 27-hydroxylase evidence for a role of this enzyme in elimination of cholesterol from human macrophages . Proc Nat Acad Sci USA. 91:1994;8592-8596.
96. Brown A.J., Watts G.F., Burnett J.R., Dean R.T., Jessup W. Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture. J Biol Chem. 275:2000;27627-27633.
97. Poli G. Phatogenesis of liver fibrosis role of oxidative stress . Molec Aspects Med. 21:2000;49-98.
98. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:1991;81-128.
99. Parola M., Robino G., Dianzani M.U. 4-Hydroxy-2,3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis. Int J Mol Med. 4:1999;425-432.
100. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanism of oxidative stress. IUBMB Life. 50:2000;315-321.
101. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 100:1997;2680-2690.
102. Ogasawara M., Nakamura T., Koyama I., Nemoto M., Yoshida T. Reactivity of taurine with aldehydes and its physiological role. Adv Exp Med Biol. 359:1994;71-78.
103. Toyokuni S., Yamada S., ashima M., Ihara Y., Yamada Y., Tanaka T., Hiai H., Seino Y., Uchida K. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal. 2:2000;681-685.
104. Nenseter M.S., Gudmundsen O., Roos N., Maelandsmo G., Drevon C.A., Berg T. Role of liver endothelial and Kupffer cells in clearing low density lipoprotein from blood in hypercholesterolemic rabbits. J Lipid Res. 33:1992;867-877.
105. Lakshmanan M.R., Veech R.L. Short- and long-term effects of ethanol administration in vivo on rat liver HMG-CoA reductase and cholesterol 7α-hydroxylase activities. J Lipid Res. 18:1977;325-330.
106. Bascoul J., Gozé C., Domergue N., Crastes de Paulet A. Serum level of 7α-hydroxycholesterol in hypercholesterolemic patients treated with cholestyramine. Biochim Biophys Acta. 1044:1990;357-360.
107. Cazzolato G., Avogaro P., Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic Biol Med. 11:1991;247-253.
108. Hodis H.N., Kramsch D.M., Avogaro P., Bittolo-Bon G., Cazzolato G., Hwang J., Peterson H., Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res. 35:1994;669-677.
109. Brown M.S., Goldstein J.L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell. 6:1975;307-316.
110. Parasassi T., Bittolo-Bon G., Brunelli R., Cazzolato G., Krasnowska E.K., Mei G., Sevanian A., Ursini F. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL-. Free Radic Biol Med. 31:2001;82-89.
111. Thewke D.P., Panini S.R., Sinensky M. Oleate potentiates oxysterol inhibition of transcription from sterol regulatory element-1 regulated promoters and maturation of sterol regulatory element-binding proteins. J Biol Chem. 273:1998;21402-21407.
112. Christ M., Luu B., Mejia J.E., Moosbrugger I., Bischoff P. Apoptosis induced by oxysterols in murine lymphoma cells and in normal thymocytes. Immunology. 78:1993;455-460.
113. Aupeix K., Weltin D., Mejia J.E., Christ M., Marchal J., Freyssinet J.M., Bischoff P. Oxysterol-induced apoptosis in human monocytic cell lines. Immunobiology. 194:1995;415-428.
114. Nishio E., Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem Biophys Res Commun. 226:1996;928-934.
115. Lizard G., Monier S., Cordelet C., Gesquiere L., Deckert V., Gueldry S., Lagrost L., Gambert P. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7β-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol. 19:1999;1190-1200.
116. Lemaire S., Lizard G., Monier S., Miguet C., Gueldry S., Volot F., Gambert P., Neel D. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett. 440:1998;434-439.
117. Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem. 273:1998;9681-9687.
118. O'Callaghan Y.C., Woods J.A., O'Brien N.M. Oxysterol-induced cell death in U937 and HepG2 cells at reduced and normal serum concentrations. Eur J Nutr. 38:1999;255-262.
119. Lizard G., Lemaire S., Monier S., Gueldry S., Neel D., Gambert P. Induction of apoptosis and of interleukin-1β secretion by 7β-hydroxycholesterol and 7-ketocholesterol partial inhibition by Bcl-2 overexpression . FEBS Lett. 419:1997;276-280.
120. Lizard G., Gueldry S., Sordet O., Monier S., Athias A., Miguet C., Bessede G., Lemaire S., Solary E., Gambert P. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 12:1998;1651-1663.
121. Ares M.P., Porn-Ares M.I., Moses S., Thyberg J., Juntti-Berggren L., Berggren P., Hultgardh-Nilsson A., Kallin B., Nilsson J. 7β-hydroxycholesterol induces Ca(2+) oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis. 153:2000;23-35.
122. Lee T., Chau L. Fas/Fas ligand mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol. 280:2001;131-138.
123. Miguet C., Monier S., Bettaieb A., Athias A., Bessede G., Laubriet A., Lemaire S., Neel D., Gambert P., Lizard G. Ceramide generation occurring during 7β-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ. 8:2001;83-99.
124. Panini S.R., Sinensky M.S. Mechanisms of oxysterol-induced apoptosis. Curr Opin Lipidol. 12:2001;529-533.
125. Daemen M.A.R.C., van't Veer C., Denecker G., Heemskerk V.H., Wolfs T.G.A.M., Clauss M., Vandenabeele P., Buurman W.A. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 104:1999;541-549.
126. Guyton J.R., Black B.L., Seidel C.L. Focal toxicity of oxysterols in vascular smooth muscle cell culture. A model of the atherosclerotic core region. Am J Pathol. 137:1990;425-434.
127. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature (London). 362:1993;801-809.
128. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb. 14:1994;47-53.
129. Jovinge S., Ares M.P., Kallin B., Nilsson J. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol. 16:1996;1573-1579.
130. Cushing S.D., Berlinger J.A., Valente A.J., Territo M.C., Navab M., Parhami F., Ross G., Schwartz C.J., Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
131. Kraemer R., Pomerantz K.B., Joseph-Silverstein J., Hajjar D.P. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. J Biol Chem. 268:1993;8040-8045.
132. Davies M.J., Gordon J.L., Gearing A.J.H., Piggott R., Woolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 171:1993;223-229.
133. Liu Y., Hulten L.M., Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol. 17:1997;317-332.
134. Landis M.S., Patel H.V., Capone J.P. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-α from human monocytes. J Biol Chem. 277:2002;4713-4721.
135. Hajjar D.P., Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem. 272:1997;22975-22978.